No abstract available
MeSH terms
-
Aged
-
Alemtuzumab
-
Antibodies, Monoclonal / administration & dosage
-
Antibodies, Monoclonal / adverse effects
-
Antibodies, Monoclonal, Humanized / pharmacology
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Dose-Response Relationship, Drug
-
Drug Resistance, Neoplasm
-
Female
-
Glucocorticoids / administration & dosage
-
Glucocorticoids / adverse effects
-
Humans
-
Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
-
Male
-
Middle Aged
-
Salvage Therapy
-
Vidarabine / analogs & derivatives
-
Vidarabine / pharmacology
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Glucocorticoids
-
Alemtuzumab
-
Vidarabine
-
ofatumumab
-
fludarabine